Connection
Abraham Nussbaum to Antipsychotic Agents
This is a "connection" page, showing publications Abraham Nussbaum has written about Antipsychotic Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.194 |
|
|
|
-
Nussbaum AM, Stroup TS. Paliperidone palmitate for schizophrenia. Schizophr Bull. 2012 Nov; 38(6):1124-7.
Score: 0.362
-
Nussbaum AM, Stroup TS. Paliperidone palmitate for schizophrenia. Cochrane Database Syst Rev. 2012 Jun 13; (6):CD008296.
Score: 0.356
-
Nussbaum AM, Stroup TS. Paliperidone for treatment of schizophrenia. Schizophr Bull. 2008 May; 34(3):419-22.
Score: 0.266
-
Rylander M, Winston HR, Medlin H, Hull M, Nussbaum A. The association of cannabis use on inpatient psychiatric hospital outcomes. Am J Drug Alcohol Abuse. 2018; 44(1):73-84.
Score: 0.126
-
Stroup TS, McEvoy JP, Ring KD, Hamer RH, LaVange LM, Swartz MS, Rosenheck RA, Perkins DO, Nussbaum AM, Lieberman JA. A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsychotics for metabolic problems (CAMP). Am J Psychiatry. 2011 Sep; 168(9):947-56.
Score: 0.084